Latest Bls Pharmaceuticals (ASX:BLS) News

Page 1
Page 1 of 1

BLS Pharmaceuticals Hits Record $75m Revenue, Locks $50m German Supply Deal

BLS Pharmaceuticals capped FY26 with record revenue and EBITDA, boosted by international expansion and major contracts, setting the stage for further growth in FY27.
Victor Sage
27 July 2026